NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1740460377 M.D.
Verify on CMS → Amit Mehta, M.D.
Hematology & Oncology Physician in Cary, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
140
Medicare Part D claims · 14 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$611.8K
695 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Amit Mehta, M.D. filed 140 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Cary, North Carolina, prescribing 48% generic.
- 140
- Part D claims, 2023
- 48%
- generic prescribing
- $611.8K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Amit Mehta, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
140 35th percentile higher than 35% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Amit Mehta, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amit Mehta, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
140 83% vs specialty avg
Specialty distribution in North Carolina
How Hematology & Oncology Physician compares to other specialties among North Carolina providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Amit Mehta, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 550 NEW WAVERLY PLACE SUITE 120, Cary, NC, 27518, with a listed phone of (919) 351-2260. NPI 1740460377 was issued on 11/12/2007.
Medicare Part D records for calendar year 2023 show 140 prescription claims written by this provider, covering 14 Medicare beneficiaries and totaling roughly $354K in drug spend, split 52% brand-name and 48% generic by claim count, with an opioid prescribing rate of 25.0%.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1740460377 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/12/2007 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amit Mehta, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$611.8K
Largest payer
EMD Serono, Inc.
Most common payment type
Travel and Lodging
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Amit Mehta, M.D. - brand share 52.0%
Hematology & Oncology Physician average
52% brand-name claims vs 48% generic, on 140 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
140
Total Claims
$354K
Total Drug Cost
14
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 168
- Total Day Supply
- 4,410
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $340K
- Generic Drug Cost
- $14K
- Opioid Claims
- 35 (25.0% rate)
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 2.41
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amit Mehta, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
22 claims
- Jakafi
Jakafi
15 claims
- Hydroxyurea
Hydroxyurea
14 claims
- Oxycontin
Oxycontin
13 claims
- Bosulif
Bosulif
11 claims
| Drug | Claims |
|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 22 |
| Jakafi Ruxolitinib Phosphate | 15 |
| Hydroxyurea | 14 |
| Oxycontin Oxycodone Hcl | 13 |
| Bosulif Bosutinib | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Hematology & Oncology Physician in NC →
All providers in North Carolina →
Compare specialties →
Hematology & Oncology Physician Overview
How Amit Mehta, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Amit Mehta, M.D.'s 140 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Mehta.
Dr. Jorge Abdallah
MD
Greenville, NC
Thomas Aberant
Durham, NC
Dr. Haritha Ackula
MBBS
Kinston, NC
Dr. Soheir Adam
MD
Durham, NC
Dr. Matthew Alberti
DO
Monroe, NC
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the North Carolina medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore North Carolina
Frequently Asked Questions
What is Amit Mehta, M.D.'s specialty? ▼
Amit Mehta, M.D. specializes in Hematology & Oncology Physician and practices in Cary, North Carolina. Credentials: M.D..
How much does Amit Mehta, M.D. prescribe under Medicare Part D? ▼
In 2023, Amit Mehta, M.D. wrote 140 Medicare Part D claims totaling $354K in drug costs for 14 beneficiaries.
Where is Amit Mehta, M.D. located? ▼
Amit Mehta, M.D. is located at 550 NEW WAVERLY PLACE SUITE 120, Cary, NC, 27518. Phone: (919) 351-2260.
What is Amit Mehta, M.D.'s NPI number? ▼
Amit Mehta, M.D.'s National Provider Identifier (NPI) is 1740460377, issued on 11/12/2007.
Does Amit Mehta, M.D. prescribe more brand-name or generic drugs? ▼
Amit Mehta, M.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $340K in brand drug costs.
Does Amit Mehta, M.D. prescribe opioids? ▼
Yes, Amit Mehta, M.D. had 35 opioid claims in 2023 with an opioid prescribing rate of 25.0%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Amit Mehta, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Amit Mehta, M.D.'s most frequently prescribed drugs include Oxycodone-Acetaminophen, Jakafi, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Amit Mehta, M.D. accept Medicare? ▼
Amit Mehta, M.D. appears in CMS Medicare data with 140 Part D claims and 14 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Amit Mehta, M.D.'s credentials? ▼
Amit Mehta, M.D.'s NPI is 1740460377 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.